Negotiators Prioritize Generic And Biosimilar Oncology Drugs Over Newer Medicines

UICC And WHO Will Bargain For Cheaper Cancer Drugs For LMICs

 
• By Chloe Kent

The Union for International Cancer Control and the World Health Organization are prioritizing off-patent drugs in their efforts to facilitate oncology medicine access in developing nations.

Pills and syringes lying on top of a sheet of paper reading 'Cancer treatment'
Lack of screening and treatment in LMICs is leading to high cancer mortality • Source: Shutterstock

More from Drug Pricing

More from Policy & Regulation